Massachusetts General Hospital

Sanofi, Mass. General Hospital launch oncology research collaboration

Thursday, October 11, 2012 07:00 AM

Global healthcare company Sanofi has formed a two-year agreement with Massachusetts General Hospital (MGH) aimed at furthering translational medicine research to develop new treatments for various types of hematological malignancies and solid tumors.

More... »

Annovation Biopharma raises $8M to develop novel anesthetics

Tuesday, September 11, 2012 08:00 AM

Annovation Biopharma, a biotech focused on safer therapies for anesthesia, has raised $8 million in a Series A financing led by Atlas Venture, Partners Innovation Fund (PIF) and new strategic investor The Medicines Company. 

More... »

Biomedical Systems to collaborate with Mass. General Hospital

Friday, August 17, 2012 03:19 PM

The imaging division of Biomedical Systems, a global provider of centralized diagnostic services, has formed a collaboration with Massachusetts General Hospital (MGH) to evaluate the efficacy of new drugs and devices.

More... »

EntreMed names two to board of directors

Tuesday, February 7, 2012 01:07 PM

EntreMed, a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, has appointed Wei-Wu He, Ph.D, executive chairman of its board of directors, and Tak W. Mak, Ph.D, as member of the board of directors.

More... »

MGH, Vall d'Hebron Hospital partner with BBVA Foundation in biomarker research

Wednesday, November 23, 2011 10:47 AM

The BBVA Foundation has reported an agreement to underwrite a joint effort between Massachusetts General Hospital and Barcelona's Vall d'Hebron Hospital to search for personalized cancer therapies through biomarker research.

More... »

Researchers use RNA technology to block inflammation

Tuesday, October 11, 2011 01:26 PM

Massachusetts General Hospital (MGH) researchers - along with collaborators from Massachusetts Institute of Technology (MIT) and Alnylam Pharmaceuticals - have found a way to block, in an animal model, the damaging inflammation that contributes to many disease conditions. In their report receiving early online publication in Nature Biotechnology, the investigators describe using small interfering RNA technology to silence the biochemical signals that attract a particular group of inflammatory cells to areas of tissue damage.

More... »

Former Genzyme chief donates $10 million to MGH

Wednesday, September 14, 2011 11:00 AM

Retired biotechnology executive Henri A. Termeer, who built Genzyme into the largest US company specializing in drugs to treat rare genetic disorders, is donating $10 million to Massachusetts General Hospital to establish it as a world leader in personalized medicine, according to the Boston Globe.

More... »

Harvard disciplines three psychiatrists under Sunshine Act

Wednesday, July 6, 2011 09:59 AM

Harvard Medical School and Massachusetts General Hospital have disciplined three faculty members in a conflict-of-interest case that became a prime exhibit in the debate over the federal Physician Payments Sunshine Act of 2010, according to the NPR Health Blog.

More... »

Dr. Ashley I. Bush joins Adeona's scientific advisory board

Friday, April 1, 2011 11:16 AM

ANN ARBOR, Mich.-based Adeona Pharmaceuticals, a developer of medicines for serious central nervous system diseases, announced that Ashley I. Bush, M.D., Ph.D., has joined the company's scientific advisory board.

More... »